Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Cogent Biosciences, Inc. (UMRX)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
10/02/2023Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)2.3k$9.55$22.4k 10/02/2023
10/02/2023Ros MatthewDirectorGrantStock Option (Right to Buy)2.2k$9.55$20.7k 10/02/2023
07/03/2023Ros MatthewDirectorGrantStock Option (Right to Buy)1.7k$11.96$20.8k 07/03/2023
07/03/2023Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)1.9k$11.96$22.5k 07/03/2023
06/07/2023Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
06/07/2023Morris ArleneDirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
06/07/2023Ros MatthewDirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
06/07/2023Shegog ToddDirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
06/07/2023CAIN CHRISTOPHER W.DirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
06/07/2023Harwin Peter EvanDirectorGrantStock Option (Right to Buy)36.7k$11.70$429.4k 06/07/2023
04/03/2023Ros MatthewDirectorGrantStock Option (Right to Buy)1.9k$10.75$20.4k 04/03/2023
01/03/2023Ros MatthewDirectorGrantStock Option (Right to Buy)1.8k$11.07$19.8k 01/03/2023
01/03/2023Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)1.9k$11.07$20.6k 01/03/2023
10/03/2022Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)1.5k$14.33$21.1k 10/03/2022
10/03/2022Ros MatthewDirectorGrantStock Option (Right to Buy)1.4k$14.33$20.3k 10/03/2022
07/01/2022Ros MatthewDirectorGrantStock Option (Right to Buy)2.2k$9.39$20.6k 07/01/2022
07/01/2022Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)2.3k$9.39$21.4k 07/01/2022
06/30/2022Sachs JessicaChief Medical OfficerGrantCommon Stock622$7.40$4.6k 06/30/2022
06/16/2022Fairmount Funds Management LLC10% OwnerPurchaseCommon Stock1.2M$8.25$9.9MFairmount Healthcare Fund II LP06/16/2022
06/07/2022Harwin Peter EvanDirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
06/07/2022CAIN CHRISTOPHER W.DirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
06/07/2022Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
06/07/2022Morris ArleneDirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
06/07/2022Ros MatthewDirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
06/07/2022Shegog ToddDirectorGrantStock Option (Right to Buy)30.7k$4.59$140.9k 06/07/2022
04/01/2022Ros MatthewDirectorGrantStock Option (Right to Buy)2.6k$7.92$21k 04/01/2022
04/01/2022Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)2.8k$7.92$21.8k 04/01/2022
01/25/2022Robbins Andrew RPresident and CEOGrantStock Option (Right to Buy)690k$7.60$5.2M 01/25/2022
01/25/2022Green John L.CFOGrantStock Option (Right to Buy)225k$7.60$1.7M 01/25/2022
01/25/2022Robinson John EdwardChief Scientific OfficerGrantStock Option (Right to Buy)250k$7.60$1.9M 01/25/2022
01/25/2022Sachs JessicaChief Medical OfficerGrantStock Option (Right to Buy)250k$7.60$1.9M 01/25/2022
01/25/2022Kearns EvanChief Legal OfficerGrantStock Option (Right to Buy)202.2k$7.60$1.5M 01/25/2022
01/03/2022Ros MatthewDirectorGrantStock Option (Right to Buy)2.3k$8.70$19.6k 01/03/2022
01/03/2022Ferrante Karen JeanDirectorGrantStock Option (Right to Buy)2.3k$8.70$20.3k 01/03/2022
12/31/2021Sachs JessicaChief Medical OfficerGrantCommon Stock674$6.82$4.6k 12/31/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy